Stock Split History
ETFs Holding ABBV »    ABBV Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid. According to our AbbVie stock split history records, AbbVie has had 0 splits.
AbbVie stock split history picture
AbbVie (ABBV) has 0 splits in our AbbVie stock split history database.

Looking at the AbbVie stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, presented on a split-history-adjusted basis factoring in the complete AbbVie stock split history. AbbVie split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 01/03/2013
End date: 11/25/2022
Start price/share: $34.83
End price/share: $159.62
Starting shares: 287.11
Ending shares: 432.65
Dividends reinvested/share: $33.55
Total return: 590.59%
Average Annual Total Return: 21.56%
Starting investment: $10,000.00
Ending investment: $69,073.54
Years: 9.90
Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/03/2013
End date: 11/25/2022
Start price/share: $34.83
End price/share: $159.62
Dividends collected/share: $33.55
Total return: 454.61%
Average Annual Total Return: 18.89%
Starting investment: $10,000.00
Ending investment: $55,441.61
Years: 9.90
Date Ratio
Astrotech Corporation (ASTC)
SuperCom (SPCB)
Qualigen Therapeutics, Inc. (QLGN)
MicroSectors Oil & Gas Exploration & Production -3X Inverse Leveraged ETNs due June 28, 2041 (OILD)
MicroSectors U.S. Big Oil Index -3X Inverse Leveraged ETNs due March 25, 2039 (NRGD)
Ebang International Holdings Inc. (EBON)
Global X Blockchain ETF (BKCH)
Global X Blockchain & Bitcoin Strategy ETF (BITS)
Global X Emerging Markets Internet & E-commerce ETF (EWEB)
Global X MSCI China Real Estate ETF (CHIR)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding AbbVie
AbbVie Insider Buying

AbbVie Stock Split History | | Copyright © 2013 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.